Dr. Jameson Azul
Endocrinology & Diabetes (Endocrinology, Diabetes & Metabolism Physician)
- Medicare participating
At a glance
- Years since graduation
- 12
- In the NPI registry since
- 2014
- Medicare patients seen, 2024
- 295
The NPI date is when this clinician registered for a National Provider Identifier, the billing number used on health claims. It is not a license, graduation or board-certification date. What an NPI is
Education and training
- 2014Registered with an NPI (national billing number; not a license date)
Medicare’s Care Compare data doesn’t list this clinician’s medical school. Undergraduate school, residency, fellowship, licensing exams and board certification aren’t in public federal data. Board certification can be confirmed with the certifying board (ABMS member boards for MDs, AOA boards for DOs).
Specialties and state licenses
-
Endocrinology, Diabetes & Metabolism Physician primary
CA license 125.065117 -
Internal Medicine Physician
CA license 125.065117 · IL license 125.065117
As reported to the NPI registry. To confirm a license is current, check the state medical board.
Where they work
Hospitals
- University of California Davis Medical Center Sacramento, CA
- Marshall Medical Center Placerville, CA
Medical groups
- Regents of the Univ of Ca (1,584 clinicians)
- Regents of the University of California (567 clinicians)
Hospitals this clinician lists with Medicare, and groups they bill Medicare through (Care Compare). Affiliation doesn’t mean they see patients at every location.
Medicare patients and services
- Medicare patients, 2024
- 295
- Services billed
- 822
- Patients’ average age
- 70
| Service | Times | Patients |
|---|---|---|
| Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 188 | 58 |
| Established patient office or other outpatient visit, 30-39 minutes | 169 | 125 |
| Established patient office or other outpatient visit, 40-54 minutes | 86 | 68 |
| New patient office or other outpatient visit, 45-59 minutes | 43 | 43 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 41 | 26 |
| Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | 32 | 30 |
| New patient office or other outpatient visit, 60-74 minutes | 25 | 25 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 19 | 19 |
Medicare fee-for-service only. CMS leaves out services billed for fewer than 11 patients. These figures describe a practice’s Medicare work; they aren’t a measure of quality.
Medicare prescriptions
| Drug | Prescriptions |
|---|---|
| Levothyroxine Sodium Other prescribers in Sacramento, CA | 160 |
| Alendronate Sodium Other prescribers in Sacramento, CA | 106 |
| Jardiance (empagliflozin) Other prescribers in Sacramento, CA | 87 |
| Trulicity (dulaglutide) Other prescribers in Sacramento, CA | 87 |
| Ozempic (semaglutide) Other prescribers in Sacramento, CA | 75 |
| Methimazole Other prescribers in Sacramento, CA | 54 |
| Lantus Solostar (insulin glargine,hum.rec.anlog) Other prescribers in Sacramento, CA | 50 |
| Forteo (teriparatide) | 39 |
| Metformin Hcl Er (metformin hcl) Other prescribers in Sacramento, CA | 34 |
| Humalog Kwikpen U-100 (insulin lispro) Other prescribers in Sacramento, CA | 30 |
Prescriptions filled under Medicare Part D, including refills. CMS leaves out drugs prescribed fewer than 11 times.
Payments from drug and device companies
In 2025, 1 companies reported 1 payments worth $135 in total to this clinician.
| Amgen Inc. | $135 |
|---|
| Food and Beverage | $135 |
|---|
From CMS Open Payments. A payment is not evidence of wrongdoing; many are for consulting, teaching or meals. Clinicians can review and dispute their records with CMS.